How severe is CVE-2023-52722?

CVE-2023-52722 has a CVSS 3.x base score of 5.5, rated medium severity. It is exploitable over local access with low attack complexity, requires no privileges and user interaction. Impact on confidentiality is none, integrity high, and availability none.

Is CVE-2023-52722 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (25th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2023-52722?

CVE-2023-52722 affects Artifex Ghostscript. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2023-52722?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.

Does CVE-2023-52722 have an EU (EUVD) identifier?

Yes. CVE-2023-52722 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2023-57346.

When was CVE-2023-52722 published?

CVE-2023-52722 was published on 2024-04-28 and last updated on 2026-06-17.

CVE-2023-52722

CVE-2023-52722 is a medium-severity vulnerability in Artifex Ghostscript with a CVSS 3.x base score of 5.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low.

Key facts

Severity: Medium (CVSS 3.x base score 5.5)
EPSS exploit prediction: 0% (25th percentile)
Actively exploited: Not listed in CISA KEV
EU (EUVD) id: EUVD-2023-57346
Affected product: Artifex Ghostscript
Published: 2024-04-28
Last modified: 2026-06-17

Description

An issue was discovered in Artifex Ghostscript before 10.03.1. psi/zmisc1.c, when SAFER mode is used, allows eexec seeds other than the Type 1 standard.

Frequently asked questions

What is CVE-2023-52722?: An issue was discovered in Artifex Ghostscript before 10.03.1. psi/zmisc1.c, when SAFER mode is used, allows eexec seeds other than the Type 1 standard.
How severe is CVE-2023-52722?: CVE-2023-52722 has a CVSS 3.x base score of 5.5, rated medium severity. It is exploitable over local access with low attack complexity, requires no privileges and user interaction. Impact on confidentiality is none, integrity high, and availability none.
Is CVE-2023-52722 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (25th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2023-52722?: CVE-2023-52722 affects Artifex Ghostscript. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2023-52722?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
Does CVE-2023-52722 have an EU (EUVD) identifier?: Yes. CVE-2023-52722 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2023-57346.
When was CVE-2023-52722 published?: CVE-2023-52722 was published on 2024-04-28 and last updated on 2026-06-17.

References

Affected products (1)

cpe:2.3:a:artifex:ghostscript:*:*:*:*:*:*:*:*

More vulnerabilities in Artifex Ghostscript

CVE-2021-3781 — Critical (CVSS 9.9): A trivial sandbox (enabled with the `-dSAFER` option) escape flaw was found in the ghostscript interpreter by injecting…
CVE-2025-27837 — Critical (CVSS 9.8): An issue was discovered in Artifex Ghostscript before 10.05.0. Access to arbitrary files can occur through a truncated…
CVE-2025-27836 — Critical (CVSS 9.8): An issue was discovered in Artifex Ghostscript before 10.05.0. The BJ10V device has a Print buffer overflow in…
CVE-2025-27832 — Critical (CVSS 9.8): An issue was discovered in Artifex Ghostscript before 10.05.0. The NPDL device has a Compression buffer overflow for…
CVE-2025-27831 — Critical (CVSS 9.8): An issue was discovered in Artifex Ghostscript before 10.05.0. The DOCXWRITE TXTWRITE device has a text buffer overflow…
CVE-2020-36773 — Critical (CVSS 9.8): Artifex Ghostscript before 9.53.0 has an out-of-bounds write and use-after-free in devices/vector/gdevtxtw.c (for…

All CVEs affecting Artifex Ghostscript →